177 related articles for article (PubMed ID: 34615796)
1. [Epigenetic abnormalities in non-Hodgkin lymphomas].
Furukawa Y
Rinsho Ketsueki; 2021; 62(9):1367-1381. PubMed ID: 34615796
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
3. [A primer for epigenetics of hematological malignancies].
Nakajima H
Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?
Lue JK; Amengual JE; O'Connor OA
Curr Oncol Rep; 2015 Sep; 17(9):40. PubMed ID: 26141799
[TBL] [Abstract][Full Text] [Related]
5. [DNA methyltransferase inhibitors * histone deacetylase inhibitors].
Kikuchi J; Furukawa Y
Nihon Rinsho; 2014 Jun; 72(6):1136-42. PubMed ID: 25016817
[TBL] [Abstract][Full Text] [Related]
6. Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma.
Hassler MR; Schiefer AI; Egger G
Epigenomics; 2013 Aug; 5(4):397-415. PubMed ID: 23895653
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Godino A; Jayanthi S; Cadet JL
Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
[TBL] [Abstract][Full Text] [Related]
8. Aberrant epigenetic gene regulation in lymphoid malignancies.
Taylor KH; Briley A; Wang Z; Cheng J; Shi H; Caldwell CW
Semin Hematol; 2013 Jan; 50(1):38-47. PubMed ID: 23507482
[TBL] [Abstract][Full Text] [Related]
9. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
10. Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications.
Hori Y; Kikuchi K
Acc Chem Res; 2019 Oct; 52(10):2849-2857. PubMed ID: 31577127
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
[TBL] [Abstract][Full Text] [Related]
12. Histone Modifications and Their Targeting in Lymphoid Malignancies.
Fernández-Serrano M; Winkler R; Santos JC; Le Pannérer MM; Buschbeck M; Roué G
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008680
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of regulatory T cells in patients with abdominal aortic aneurysm.
Xia Q; Zhang J; Han Y; Zhang X; Jiang H; Lun Y; Wu X; Gang Q; Liu Z; Böckler D; Duan Z; Xin S
FEBS Open Bio; 2019 Jun; 9(6):1137-1143. PubMed ID: 31001930
[TBL] [Abstract][Full Text] [Related]
14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of lymphomas in the era of epigenetics.
Chebly A; Chouery E; Ropio J; Kourie HR; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Blood Rev; 2021 Jul; 48():100782. PubMed ID: 33229141
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetics of schizophrenia: a review].
Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
[TBL] [Abstract][Full Text] [Related]
18. Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Fratta E; Montico B; Rizzo A; Colizzi F; Sigalotti L; Dolcetti R
Oncotarget; 2016 Aug; 7(35):57327-57350. PubMed ID: 27329599
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of airway inflammation.
Adcock IM; Tsaprouni L; Bhavsar P; Ito K
Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
[TBL] [Abstract][Full Text] [Related]
20. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
Ma H; O'Connor OA; Marchi E
Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
